The Indonesian Government has issued various policies to fight Coronavirus Disease (COVID-19). However, cases have continued to fluctuate over a year into the pandemic. There is a need to assess the country's healthcare system's capacity to absorb and accommodate the varying healthcare demands. We reviewed the current capacity of Indonesia's healthcare system to respond to COVID-19 based on the four essential elements of surge capacity: staff, stuff, structure, and system. Currently available medical staffs are insufficient to deal with potentially increasing demands as the pandemic highlighted the human resources challenges the healthcare system has been struggling with. The pandemic has exposed the fragility of medical supply chains. Surges in the number of patients requiring hospitalization have led to depleted medical supplies. The existing healthcare infrastructure is still inadequate to deal with the rise of COVID-19 cases, which has also exposed the limited capacity of the healthcare infrastructure to manage medical waste. The COVID-19 pandemic has further exposed the weakness of the patient referral system and the limited capacity of the healthcare system to deliver essential health services under prolonged emergencies. The Indonesian Government needs to ramp up the country's healthcare capacity. A wide range of strategies has been proposed to address those mounting challenges. Notwithstanding, the challenges of increasing healthcare capacity highlight that such efforts could represent only one part of the pandemic response equation. Effective pandemic response ultimately requires governments' commitment to increase healthcare capacity and flatten the curve concurrently.
Background: Drug management realizes the availability of drugs needed to be effective and efficient, especially during the COVID-19 pandemic. The high use of COVID-19 drugs makes several types of drugs needed to experience vacancies, and due to changes in government regulations make some COVID-19 drugs stagnant.Objectives: To evaluate the supply of COVID-19 drugs during the pandemic and the factors that influence it in government and private hospitals in Makassar CityMethods: This study is a mixed-method study with a sequential explanatory design. Quantitative data were obtained retrospectively from January to December 2021 by searching drug management documents. Qualitative data was obtained through in-depth interviews with 12 informants.Results: The availability of COVID-19 drugs in government hospitals is 19.3 months, while in private hospitals, it is 13.6 months. Factors that affect drug supply are the method of planning drug needs, Lead Time, and several changes in guidelines.Conclusions: The supply of COVID-19 drugs is still excessive at that Public Hospital, and the factor that most influenced the supply of COVID-19 drugs was changes in guidelines.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.